Invention Grant
- Patent Title: Tissue specific gene therapy treatment
- Patent Title (中): 组织特异性基因治疗
-
Application No.: US12447558Application Date: 2007-10-30
-
Publication No.: US08383601B2Publication Date: 2013-02-26
- Inventor: Walter J. Koch , Patrick Most , Sven T. Pleger , Joseph E. Rabinowitz
- Applicant: Walter J. Koch , Patrick Most , Sven T. Pleger , Joseph E. Rabinowitz
- Applicant Address: US PA Philadelphia
- Assignee: Thomas Jefferson University
- Current Assignee: Thomas Jefferson University
- Current Assignee Address: US PA Philadelphia
- Agency: Nixon Peabody LLP
- Agent David S. Resnick; Tari W. Mills
- International Application: PCT/US2007/022861 WO 20071030
- International Announcement: WO2008/054713 WO 20080508
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N15/11 ; C12N5/00

Abstract:
The invention provides nucleic acid segments, compositions and methods for the treatment of heart failure, vascular dysfunction, endothelial dysfunction, diabetes, [Ca2+]i regulation and NO synthase dysfunction. Adeno-associated and adenovirus are used as gene delivery vectors for the nucleic acid segments to product long term over-expression of S100A1, a small calcium sensing protein associated with the disclosed ailments and dysfunctions.
Public/Granted literature
- US20100190840A1 TISSUE SPECIFIC GENE THERAPY TREATMENT Public/Granted day:2010-07-29
Information query